Share Price and Basic Stock Data
Last Updated: November 15, 2025, 10:41 pm
| PEG Ratio | 2.29 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
CCL International Ltd operates in the Trading & Distributors sector, with a current market capitalization of ₹59.5 Cr. The company’s stock price is ₹31.0, reflecting a price-to-earnings (P/E) ratio of 52.2. Historically, CCL International’s revenue has shown significant fluctuations, with sales recorded at ₹26.80 Cr in FY 2022 and rising to ₹14.35 Cr in FY 2023. The trailing twelve months (TTM) sales stood at ₹47.59 Cr, indicating a recovery trajectory. Notably, quarterly sales saw a remarkable spike to ₹36.01 Cr in Mar 2025, showcasing the company’s potential for growth. The sales performance is complemented by a consistent operational profit margin (OPM) of 12.89%, highlighting the company’s ability to maintain profitability despite varying revenue levels. However, the revenue trends have also shown vulnerability, with a decline to ₹0.06 Cr in Dec 2022, emphasizing the need for stable demand management and sales strategies.
Profitability and Efficiency Metrics
CCL International reported a net profit of ₹1.14 Cr for FY 2025, with earnings per share (EPS) at ₹1.59, reflecting a notable recovery from the previous years, where the company recorded a net loss of ₹1.39 Cr in FY 2023. The return on equity (ROE) stood at 1.47%, and the return on capital employed (ROCE) was reported at 3.35%, indicating moderate efficiency in utilizing equity and capital for profit generation. The company’s operating profit margins have fluctuated, peaking at 17.35% in Mar 2022 but stabilizing at 12.89% for the latest period. CCL International’s cash conversion cycle (CCC) was reported at 110.18 days, which is relatively high, indicating potential inefficiencies in inventory and receivables management. This extended CCC could pose challenges in working capital management and liquidity, necessitating strategic improvements in operational efficiencies.
Balance Sheet Strength and Financial Ratios
The balance sheet of CCL International reflects a total asset value of ₹75.46 Cr for FY 2025, with total borrowings amounting to ₹24.05 Cr. The company’s reserves have increased to ₹28.07 Cr, demonstrating a solid equity base. The debt-to-equity ratio stands at 0.39, suggesting a conservative capital structure relative to its equity base. CCL International’s interest coverage ratio (ICR) is reported at 3.95x, indicating a strong ability to service its debt obligations. However, the price-to-book value (P/BV) ratio of 0.43x suggests that the stock may be undervalued in the market relative to its book value. The company has consistently maintained a current ratio above 1, ensuring adequate liquidity to cover short-term liabilities. Nevertheless, the declining trend in net profit margins, which fell to 0.72% in FY 2025 from 2.14% in FY 2020, raises concerns about profitability sustainability.
Shareholding Pattern and Investor Confidence
As of Mar 2025, the promoter holding in CCL International stood at 63.85%, indicating a strong commitment from the management. Foreign institutional investors (FIIs) hold a negligible stake of 0.01%, reflecting limited foreign interest in the company. Public shareholders comprised 36.14% of the total ownership, with the number of shareholders increasing to 3,047, up from 2,261 in Sep 2022. This growth in shareholder base suggests increasing interest from domestic investors. However, the low FII participation may indicate a lack of confidence in the company from international investors. The stability in promoter holdings, coupled with a consistent increase in public shareholders, could enhance investor confidence, but the overall low institutional interest remains a concern for potential growth and visibility in the market.
Outlook, Risks, and Final Insight
Looking ahead, CCL International’s growth potential hinges on its ability to stabilize revenue generation and improve operational efficiencies. The significant rise in quarterly sales to ₹36.01 Cr in Mar 2025 indicates a positive trend, but the company must also address its high cash conversion cycle to enhance liquidity. Risks include reliance on domestic markets, which can be volatile, and the company’s historical fluctuations in profitability. Furthermore, the minimal foreign institutional investment could limit access to broader capital markets. On the strength side, the solid promoter holding and improving net profit figures offer a foundation for future growth. Should the company successfully streamline operations and attract more institutional investors, it could see a substantial uplift in its market position. Conversely, failure to manage its working capital effectively could hinder its recovery efforts.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of CCL International Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 68.9 Cr. | 3.59 | 5.59/3.20 | 45.9 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 12.6 Cr. | 14.3 | 18.6/13.0 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.37 Cr. | 70.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 93.7 Cr. | 45.7 | 49.8/10.2 | 92.8 | 15.0 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 107 Cr. | 96.0 | 174/84.4 | 15.1 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 11,409.25 Cr | 164.48 | 101.45 | 117.47 | 0.39% | 15.44% | 8.88% | 7.74 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.85 | 2.57 | 5.07 | 0.06 | 8.74 | 5.68 | 3.26 | 10.45 | 16.31 | 6.84 | 0.46 | 2.52 | 36.01 |
| Expenses | 13.10 | 2.48 | 4.44 | 1.91 | 7.24 | 4.79 | 2.88 | 9.37 | 14.00 | 5.87 | 0.96 | 3.13 | 31.37 |
| Operating Profit | 2.75 | 0.09 | 0.63 | -1.85 | 1.50 | 0.89 | 0.38 | 1.08 | 2.31 | 0.97 | -0.50 | -0.61 | 4.64 |
| OPM % | 17.35% | 3.50% | 12.43% | -3,083.33% | 17.16% | 15.67% | 11.66% | 10.33% | 14.16% | 14.18% | -108.70% | -24.21% | 12.89% |
| Other Income | 0.77 | 0.60 | 0.07 | 0.14 | 0.07 | 0.08 | 0.35 | 0.47 | 0.16 | 0.10 | 0.12 | 0.12 | 0.25 |
| Interest | 0.31 | 0.13 | 0.14 | 0.22 | 0.26 | 0.20 | 0.13 | 0.33 | 1.23 | 0.25 | 0.18 | 0.17 | 0.89 |
| Depreciation | 0.64 | 0.55 | 0.55 | 0.74 | 0.63 | 0.67 | 0.60 | 0.82 | 0.76 | 0.66 | 0.66 | 0.68 | 0.68 |
| Profit before tax | 2.57 | 0.01 | 0.01 | -2.67 | 0.68 | 0.10 | 0.00 | 0.40 | 0.48 | 0.16 | -1.22 | -1.34 | 3.32 |
| Tax % | 3.11% | -100.00% | -100.00% | -27.34% | 23.53% | -20.00% | -2.50% | -95.83% | 12.50% | -4.92% | -0.75% | 8.43% | |
| Net Profit | 2.50 | 0.02 | 0.01 | -1.94 | 0.52 | 0.11 | 0.00 | 0.41 | 0.95 | 0.15 | -1.16 | -1.32 | 3.05 |
| EPS in Rs | 1.30 | 0.01 | 0.01 | -1.01 | 0.27 | 0.06 | 0.00 | 0.21 | 0.49 | 0.08 | -0.60 | -0.69 | 1.59 |
Last Updated: July 16, 2025, 10:28 am
Below is a detailed analysis of the quarterly data for CCL International Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 36.01 Cr.. The value appears strong and on an upward trend. It has increased from 2.52 Cr. (Dec 2024) to 36.01 Cr., marking an increase of 33.49 Cr..
- For Expenses, as of Mar 2025, the value is 31.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.13 Cr. (Dec 2024) to 31.37 Cr., marking an increase of 28.24 Cr..
- For Operating Profit, as of Mar 2025, the value is 4.64 Cr.. The value appears strong and on an upward trend. It has increased from -0.61 Cr. (Dec 2024) to 4.64 Cr., marking an increase of 5.25 Cr..
- For OPM %, as of Mar 2025, the value is 12.89%. The value appears strong and on an upward trend. It has increased from -24.21% (Dec 2024) to 12.89%, marking an increase of 37.10%.
- For Other Income, as of Mar 2025, the value is 0.25 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Dec 2024) to 0.25 Cr., marking an increase of 0.13 Cr..
- For Interest, as of Mar 2025, the value is 0.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.17 Cr. (Dec 2024) to 0.89 Cr., marking an increase of 0.72 Cr..
- For Depreciation, as of Mar 2025, the value is 0.68 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.68 Cr..
- For Profit before tax, as of Mar 2025, the value is 3.32 Cr.. The value appears strong and on an upward trend. It has increased from -1.34 Cr. (Dec 2024) to 3.32 Cr., marking an increase of 4.66 Cr..
- For Tax %, as of Mar 2025, the value is 8.43%. The value appears to be increasing, which may not be favorable. It has increased from -0.75% (Dec 2024) to 8.43%, marking an increase of 9.18%.
- For Net Profit, as of Mar 2025, the value is 3.05 Cr.. The value appears strong and on an upward trend. It has increased from -1.32 Cr. (Dec 2024) to 3.05 Cr., marking an increase of 4.37 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.59. The value appears strong and on an upward trend. It has increased from -0.69 (Dec 2024) to 1.59, marking an increase of 2.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78.36 | 92.63 | 75.81 | 64.08 | 33.22 | 37.11 | 24.80 | 30.08 | 26.80 | 14.35 | 32.22 | 44.69 | 47.59 |
| Expenses | 75.76 | 89.11 | 72.05 | 63.85 | 29.08 | 32.29 | 22.60 | 26.14 | 23.65 | 13.96 | 27.57 | 40.18 | 42.99 |
| Operating Profit | 2.60 | 3.52 | 3.76 | 0.23 | 4.14 | 4.82 | 2.20 | 3.94 | 3.15 | 0.39 | 4.65 | 4.51 | 4.60 |
| OPM % | 3.32% | 3.80% | 4.96% | 0.36% | 12.46% | 12.99% | 8.87% | 13.10% | 11.75% | 2.72% | 14.43% | 10.09% | 9.67% |
| Other Income | 0.59 | 0.58 | 0.39 | 5.59 | -0.57 | 1.23 | 4.40 | 0.34 | 0.99 | 0.87 | 1.07 | 0.59 | 0.95 |
| Interest | 0.66 | 1.31 | 1.63 | 1.44 | 1.55 | 1.53 | 1.90 | 1.01 | 1.00 | 0.76 | 1.89 | 1.49 | 1.61 |
| Depreciation | 1.13 | 1.28 | 1.27 | 1.43 | 1.82 | 2.30 | 2.51 | 2.62 | 2.56 | 2.47 | 2.85 | 2.68 | 2.64 |
| Profit before tax | 1.40 | 1.51 | 1.25 | 2.95 | 0.20 | 2.22 | 2.19 | 0.65 | 0.58 | -1.97 | 0.98 | 0.93 | 1.30 |
| Tax % | 28.57% | 31.79% | 32.00% | -5.08% | 55.00% | 9.46% | 2.28% | 26.15% | 3.45% | -29.95% | -50.00% | 23.66% | |
| Net Profit | 0.99 | 1.03 | 0.85 | 3.10 | 0.08 | 2.01 | 2.14 | 0.48 | 0.57 | -1.39 | 1.47 | 0.72 | 1.14 |
| EPS in Rs | 0.52 | 0.54 | 0.44 | 1.62 | 0.04 | 1.05 | 1.12 | 0.25 | 0.30 | -0.72 | 0.77 | 0.38 | 0.60 |
| Dividend Payout % | 48.46% | 46.58% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 4.04% | -17.48% | 264.71% | -97.42% | 2412.50% | 6.47% | -77.57% | 18.75% | -343.86% | 205.76% | -51.02% |
| Change in YoY Net Profit Growth (%) | 0.00% | -21.52% | 282.18% | -362.13% | 2509.92% | -2406.03% | -84.04% | 96.32% | -362.61% | 549.62% | -256.78% |
CCL International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 13% |
| 3 Years: | 20% |
| TTM: | 29% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 20% |
| 3 Years: | 82% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -18% |
| 5 Years: | 19% |
| 3 Years: | 19% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 2:51 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 55.57 | 6.23 | 66.59 | 66.81 | 79.11 | 109.27 | 251.38 | 112.97 | 272.52 | 207.30 | 182.61 | 110.18 |
| Inventory Days | 67.61 | 68.61 | 63.26 | 123.89 | 131.56 | 104.55 | 145.93 | 99.74 | 84.97 | |||
| Days Payable | 109.87 | 65.19 | 71.94 | 83.47 | 112.29 | 24.76 | 76.59 | 52.96 | 57.23 | |||
| Cash Conversion Cycle | 13.31 | 9.65 | 57.91 | 107.23 | 98.39 | 189.06 | 320.71 | 159.75 | 300.27 | 207.30 | 182.61 | 110.18 |
| Working Capital Days | 2.98 | 6.97 | 40.25 | 51.09 | 109.87 | 135.93 | 270.81 | 242.32 | 330.00 | 613.00 | 246.51 | 182.21 |
| ROCE % | 4.54% | 5.86% | 5.89% | -1.06% | 5.67% | 5.71% | 0.41% | 2.84% | 1.83% | -2.96% | 3.59% | 3.35% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 19 | Mar 18 | Mar 17 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.07 | 0.36 | 1.60 |
| Diluted EPS (Rs.) | 1.07 | 0.36 | 1.60 |
| Cash EPS (Rs.) | 2.24 | 0.99 | 2.36 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 22.45 | 21.46 | 21.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 22.45 | 21.46 | 21.09 |
| Revenue From Operations / Share (Rs.) | 19.33 | 17.31 | 34.07 |
| PBDIT / Share (Rs.) | 3.15 | 1.86 | 3.03 |
| PBIT / Share (Rs.) | 1.96 | 0.91 | 2.29 |
| PBT / Share (Rs.) | 1.16 | 0.10 | 1.54 |
| Net Profit / Share (Rs.) | 1.05 | 0.04 | 1.62 |
| NP After MI And SOA / Share (Rs.) | 1.07 | 0.36 | 1.60 |
| PBDIT Margin (%) | 16.31 | 10.74 | 8.89 |
| PBIT Margin (%) | 10.11 | 5.26 | 6.71 |
| PBT Margin (%) | 5.98 | 0.59 | 4.51 |
| Net Profit Margin (%) | 5.41 | 0.25 | 4.74 |
| NP After MI And SOA Margin (%) | 5.53 | 2.10 | 4.69 |
| Return on Networth / Equity (%) | 4.76 | 1.69 | 7.57 |
| Return on Capital Employeed (%) | 7.85 | 3.81 | 10.57 |
| Return On Assets (%) | 2.97 | 1.07 | 4.35 |
| Long Term Debt / Equity (X) | 0.09 | 0.09 | 0.01 |
| Total Debt / Equity (X) | 0.39 | 0.25 | 0.24 |
| Asset Turnover Ratio (%) | 0.55 | 0.49 | 0.00 |
| Current Ratio (X) | 1.93 | 2.06 | 1.53 |
| Quick Ratio (X) | 1.53 | 1.56 | 1.01 |
| Interest Coverage Ratio (X) | 3.95 | 2.30 | 4.05 |
| Interest Coverage Ratio (Post Tax) (X) | 2.31 | 1.05 | 3.16 |
| Enterprise Value (Cr.) | 29.52 | 25.01 | 43.79 |
| EV / Net Operating Revenue (X) | 0.79 | 0.75 | 0.66 |
| EV / EBITDA (X) | 4.88 | 7.00 | 7.53 |
| MarketCap / Net Operating Revenue (X) | 0.50 | 0.73 | 0.61 |
| Price / BV (X) | 0.43 | 0.58 | 0.99 |
| Price / Net Operating Revenue (X) | 0.50 | 0.73 | 0.61 |
| EarningsYield | 0.11 | 0.02 | 0.07 |
After reviewing the key financial ratios for CCL International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 19, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For Diluted EPS (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 5. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For Cash EPS (Rs.), as of Mar 19, the value is 2.24. This value is below the healthy minimum of 3. It has increased from 0.99 (Mar 18) to 2.24, marking an increase of 1.25.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 22.45. It has increased from 21.46 (Mar 18) to 22.45, marking an increase of 0.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 22.45. It has increased from 21.46 (Mar 18) to 22.45, marking an increase of 0.99.
- For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 19.33. It has increased from 17.31 (Mar 18) to 19.33, marking an increase of 2.02.
- For PBDIT / Share (Rs.), as of Mar 19, the value is 3.15. This value is within the healthy range. It has increased from 1.86 (Mar 18) to 3.15, marking an increase of 1.29.
- For PBIT / Share (Rs.), as of Mar 19, the value is 1.96. This value is within the healthy range. It has increased from 0.91 (Mar 18) to 1.96, marking an increase of 1.05.
- For PBT / Share (Rs.), as of Mar 19, the value is 1.16. This value is within the healthy range. It has increased from 0.10 (Mar 18) to 1.16, marking an increase of 1.06.
- For Net Profit / Share (Rs.), as of Mar 19, the value is 1.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 18) to 1.05, marking an increase of 1.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 1.07. This value is below the healthy minimum of 2. It has increased from 0.36 (Mar 18) to 1.07, marking an increase of 0.71.
- For PBDIT Margin (%), as of Mar 19, the value is 16.31. This value is within the healthy range. It has increased from 10.74 (Mar 18) to 16.31, marking an increase of 5.57.
- For PBIT Margin (%), as of Mar 19, the value is 10.11. This value is within the healthy range. It has increased from 5.26 (Mar 18) to 10.11, marking an increase of 4.85.
- For PBT Margin (%), as of Mar 19, the value is 5.98. This value is below the healthy minimum of 10. It has increased from 0.59 (Mar 18) to 5.98, marking an increase of 5.39.
- For Net Profit Margin (%), as of Mar 19, the value is 5.41. This value is within the healthy range. It has increased from 0.25 (Mar 18) to 5.41, marking an increase of 5.16.
- For NP After MI And SOA Margin (%), as of Mar 19, the value is 5.53. This value is below the healthy minimum of 8. It has increased from 2.10 (Mar 18) to 5.53, marking an increase of 3.43.
- For Return on Networth / Equity (%), as of Mar 19, the value is 4.76. This value is below the healthy minimum of 15. It has increased from 1.69 (Mar 18) to 4.76, marking an increase of 3.07.
- For Return on Capital Employeed (%), as of Mar 19, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 3.81 (Mar 18) to 7.85, marking an increase of 4.04.
- For Return On Assets (%), as of Mar 19, the value is 2.97. This value is below the healthy minimum of 5. It has increased from 1.07 (Mar 18) to 2.97, marking an increase of 1.90.
- For Long Term Debt / Equity (X), as of Mar 19, the value is 0.09. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 18) which recorded 0.09.
- For Total Debt / Equity (X), as of Mar 19, the value is 0.39. This value is within the healthy range. It has increased from 0.25 (Mar 18) to 0.39, marking an increase of 0.14.
- For Asset Turnover Ratio (%), as of Mar 19, the value is 0.55. It has increased from 0.49 (Mar 18) to 0.55, marking an increase of 0.06.
- For Current Ratio (X), as of Mar 19, the value is 1.93. This value is within the healthy range. It has decreased from 2.06 (Mar 18) to 1.93, marking a decrease of 0.13.
- For Quick Ratio (X), as of Mar 19, the value is 1.53. This value is within the healthy range. It has decreased from 1.56 (Mar 18) to 1.53, marking a decrease of 0.03.
- For Interest Coverage Ratio (X), as of Mar 19, the value is 3.95. This value is within the healthy range. It has increased from 2.30 (Mar 18) to 3.95, marking an increase of 1.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 2.31. This value is below the healthy minimum of 3. It has increased from 1.05 (Mar 18) to 2.31, marking an increase of 1.26.
- For Enterprise Value (Cr.), as of Mar 19, the value is 29.52. It has increased from 25.01 (Mar 18) to 29.52, marking an increase of 4.51.
- For EV / Net Operating Revenue (X), as of Mar 19, the value is 0.79. This value is below the healthy minimum of 1. It has increased from 0.75 (Mar 18) to 0.79, marking an increase of 0.04.
- For EV / EBITDA (X), as of Mar 19, the value is 4.88. This value is below the healthy minimum of 5. It has decreased from 7.00 (Mar 18) to 4.88, marking a decrease of 2.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 18) to 0.50, marking a decrease of 0.23.
- For Price / BV (X), as of Mar 19, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 18) to 0.43, marking a decrease of 0.15.
- For Price / Net Operating Revenue (X), as of Mar 19, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 0.73 (Mar 18) to 0.50, marking a decrease of 0.23.
- For EarningsYield, as of Mar 19, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 18) to 0.11, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CCL International Ltd:
- Net Profit Margin: 5.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.85% (Industry Average ROCE: 15.44%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.76% (Industry Average ROE: 8.88%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.53
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.1 (Industry average Stock P/E: 101.45)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.41%
CCL International Ltd: Intrinsic Value & Share Price Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | M-4, Gupta Tower, B 1/1, Commercial Complex, New Delhi Delhi 110033 | cclinternational2008@gmail.com http://www.evocreteindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Akash Gupta | Chairman & Managing Director |
| Mrs. Rama Gupta | Non Executive Director |
| Mr. Arvind Sharma | Independent Director |
| Ms. Sonam Sharma | Independent Director |
| Mr. Sandeep Kumar Garg | Independent Director |